Skip to main content

UBS Group AG

Position in SMMT — Summit Therapeutics Inc.

CIK 1610520 ZURICH, V8

Position in SMMT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$76,256,436
+$6,477,665 QoQ
Shares Held
5,233,798
+42.2% QoQ
Ownership
0.656%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#6
of 242 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Derivatives in SMMT

reported options exposure · as of Jun 30, 2026
CallValue
$1,054,868
CallShares
72,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. SMMT ranks #26 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SMMT

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,054,868 72,400
2026-06-30 $76,256,436 5,233,798
2026-03-31 $379,200 20,000
2026-03-31 $69,778,771 3,680,315
2025-12-31 $15,228,874 870,719
2025-09-30 $1,756,100 85,000
2025-09-30 $26,419,655 1,278,783
2025-06-30 $44,559,425 2,093,958
2025-03-31 $24,386,860 1,264,223
2024-12-31 $21,170,415 1,186,350
2024-09-30 $2,624,035 119,819
2024-06-30 $1,309,361 167,867
2024-03-31 $1,974,539 476,942
2023-12-31 $394,809 151,268
2023-09-30 $182,859 97,786
2023-06-30 $131,360 52,335
2023-03-31 $284,264 162,437
2022-12-31 $10,319 2,428
2022-09-30 $58,600 49,245
2022-06-30 $63,336 63,336
2022-03-31 $201,375 82,194
2021-12-31 $312,854 116,303
2021-09-30 $622,947 124,341
2021-06-30 $930,963 124,794
2021-03-31 $739,461 125,973
2020-12-31 $649,948 138,287
2020-09-30 $484,902 140,960